(Q86505712)
Statements
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial (English)
Masanori Emoto
Yasuo Terauchi
Akichika Ozeki
Tomonori Oura
Masakazu Takeuchi
Takeshi Imaoka
17 October 2015